Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Clinical trial NCT04715997 · COMPLETED
Trial details
- NCT number
- NCT04715997
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-04-19
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.